Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2011/06/001813
CTRI/2011/06/001813
Completed
Phase 4

Assessment of Efficacy, Safety and Tolerability of Hair4U 10% (minoxidil 10% plus Aminexil 1.5%) in the treatment of Androgenetic Alopecia

Glenmark Pharmaceuticals Ltd0 sites75 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Androgenetic Alopecia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Androgenetic Alopecia
Sponsor
Glenmark Pharmaceuticals Ltd
Enrollment
75
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Subjects with androgenetic alopecia grade from II to IV.
  • •Male subjects must be between 18\-50years of age.
  • •Subject must provide informed consent and comply with protocol.

Exclusion Criteria

  • •Subjects not willing to discontinue all the treatments of androgenetic alopecia 2 weeks prior to enrollement in the study.
  • •hypersensitivity o any of the ingredients.
  • •subjects taking concomitant therapy that might interfere with the study results in investigators opinion.
  • •subjects with dermatological disorder of scalp that miht interfere with study evaluation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
A Clinical trial to study the effects and tolerability of Dacne gel containing Clindamycin Phosphate 1% and zinc acetate in patients suffering from acne.
CTRI/2011/091/000041Glenmark Pharmaceuticals Ltd125
Completed
Phase 4
Assessment of Efficacy, Safety and Tolerability of Fixed Dose Combination Wunder Eye Cream (3% Biophytex LS 8740 an 5% Proteasyl TP LS 8657) in the treatment of under Eye Dark Circles.
CTRI/2011/04/001672Glenmark Pharmaceuticals Limited20
Completed
N/A
Observational Study on cough syrupHealth Condition 1: null- productive cough (cough with expectoration) associated with any of the nasal symptoms (nasal discharge,nasal stuffiness, nasal itching, and Sneezing) since at least previous 8 hours
CTRI/2015/09/006198Dr Reddys laboratories Ltd250
Completed
Phase 4
Study of Efficacy, Safety and Tolerability of Na-Picosulphate in patients requiring anorectal surgeryHealth Condition 1: null- Patients requiring bowel preparation for gastrointestinal or anorectal surgery
CTRI/2016/09/007292VYAS SURGERY100
Recruiting
Phase 4
Assessment of Steroneo Skin Cream (Physalis Angulata Supercritical Extract) application for treatment of eczematous lesions
CTRI/2016/11/007511Rehmat Clinic50